Alnylam Pharmaceuticals, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ALNY Nasdaq 2836 www.alnylam.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Alnylam Pharmaceuticals, Inc.

Implied Volatility Surging for Alnylam Pharmaceuticals Stock Options - Aug 6th, 2026 6:30 am
Tenaya Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update - Aug 5th, 2026 2:05 pm
Alnylam (ALNY) Q2 2026 Earnings Call Transcript - Aug 3rd, 2026 7:54 pm
Starbucks upgraded, eBay downgraded: Wall Street's top analyst calls - Aug 3rd, 2026 7:49 am
Is The Recent Pullback In Alnylam Stock An Opportunity Or A Trap? - Jul 31st, 2026 1:29 pm
ALNY Stock Tanks 28% as Q2 Earnings Miss Estimates, '26 Sales View Cut - Jul 31st, 2026 9:25 am
US Stock Market Today: S&P 500 Futures Inch Higher As Inflation Data Looms - Jul 31st, 2026 2:09 am
Alnylam Pharma (ALNY) Q2 2026 Earnings Call Transcript - Jul 30th, 2026 9:20 pm
Alnylam Pharmaceuticals Inc (ALNY) (Q2 2026) Earnings Call Highlights: Amvuttra Surpasses $1 ... - Jul 30th, 2026 3:04 pm
US Equity Markets End Higher on Microsoft's Cloud Gains, Semiconductor Rebound - Jul 30th, 2026 2:17 pm
Alnylam plunges as earnings deliver ‘one-two punch’ - Jul 30th, 2026 10:12 am
Alnylam Pharmaceuticals Q2 Earnings Call Highlights - Jul 30th, 2026 8:04 am
Alnylam (ALNY) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Jul 30th, 2026 8:00 am
Alnylam Pharmaceuticals (ALNY) Misses Q2 Earnings and Revenue Estimates - Jul 30th, 2026 7:35 am
Alnylam Pharmaceuticals (ALNY) Could Be 34% Undervalued After Alzheimer’s Pipeline Update - Jul 29th, 2026 5:12 pm
Alnylam (ALNY) Is Up 6.3% After Showcasing New Alzheimer’s RNAi Data And $1B-Plus Quarterly Revenue - Jul 29th, 2026 12:10 pm
Unlocking Q2 Potential of Alnylam (ALNY): Exploring Wall Street Estimates for Key Metrics - Jul 28th, 2026 7:15 am
Why Alnylam’s Best Quarter Ever Didn’t Come With a Richer Valuation - Jul 28th, 2026 2:16 am
CRISPR Therapeutics AG (CRSP) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Jul 27th, 2026 8:00 am
Is Arrowhead Pharmaceuticals Stock A Smart Buy After Its Transition To A Commercial Company? - Jul 23rd, 2026 9:00 am